Prognostic Significance of Tumor Hypoxia Inducible Factor-1α Expression for Outcome After Radiotherapy in Oropharyngeal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 5, 2008, Pages 1551-1559

  Silva, Priyamal ^a,b   Slevin, Nick J ^b   Sloan, Philip ^c   Valentine, Helen ^a   Cresswell, Jo ^a   Ryder, David ^b   Price, Patricia ^a   Homer, Jarrod J ^b,c   West, Catharine M L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Hemoglobin; HIF 1 ; Oropharynx; Radiotherapy; Subsites

Indexed keywords

BIOLOGY; DECISION MAKING; DISEASE CONTROL; MULTIVARIANT ANALYSIS; RADIOTHERAPY;

CLINICAL PARAMETERS; CONFIDENCE INTERVALS; HAZARD RATIOS; HOMOGENEOUS GROUPS; INTER-RELATIONSHIPS; LOCOREGIONAL CONTROLS; MANAGEMENT DECISIONS; MOLECULAR MARKERS; MULTIVARIATE ANALYSES; OROPHARYNGEAL CANCERS; OROPHARYNX; PROGNOSTIC FACTORS; PROGNOSTIC SIGNIFICANCES; RADIATION THERAPIES; SQUAMOUS CELL CARCINOMATA; SUBSITES; TUMOR BIOLOGIES; TUMOR HYPOXIAS;

TUMORS;

HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HEMOGLOBINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 56349104567     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.07.051     Document Type: Article

References (35)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Cancer Research UK Information Resource. http://info.cancerresearchuk.org/cancerstats.2005.
3. Vikram B. Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 110 (1984) 564-565
4. Erkal H.S., Mendenhall W.M., Amdur R.J., et al. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol 19 (2001) 1358-1362
5. Snow G.B., Annyas A.A., van Slooten E.A., et al. Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci 7 (1982) 185-192
6. Nix P.A., Greenman J., Cawkwell L., et al. Radioresistant laryngeal cancer: Beyond the TNM stage. Clin Otolaryngol Allied Sci 29 (2004) 105-114
7. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
8. Nordsmark M., Bentzen S.M., Rudat V., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77 (2005) 18-24
9. Lal A P.H., St Croix B., et al. Transcriptional response to hypoxia in human tumours. J Natl Cancer Inst 93 (2001) 1337-1343
10. Aebersold D.M., Burri P., Beer K.T., et al. Expression of hypoxia-inducible factor-1alpha: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61 (2001) 2911-2916
11. Hui E.P., Chan A.T., Pezzella F., et al. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 8 (2002) 2595-2604
12. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 1192-1202
13. Beasley N.J., Leek R., Alam M., et al. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: Relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 62 (2002) 2493-2497
14. Fillies T., Werkmeister R., van Diest P.J., et al. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer 5 (2005) 84
15. Kyzas P.A., Stefanou D., Batistatou A., et al. Hypoxia-induced tumor angiogenic pathway in head and neck cancer: An in vivo study. Cancer Lett 225 (2005) 297-304
16. Amdur R.J., Parsons J.T., Mendenhall W.M., et al. Postoperative irradiation for squamous cell carcinoma of the head and neck: An analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 16 (1989) 25-36
17. Hunter K.D., Parkinson E.K., and Harrison P.R. Profiling early head and neck cancer. Nat Rev Cancer 5 (2005) 127-135
18. Chang B.W., Kim D.H., Kowalski D.P., et al. Prognostic significance of cyclooxygenase-2 in oropharyngeal squamous cell carcinoma. Clin Cancer Res 10 (2004) 1678-1684
19. Johansen L.V., Grau C., and Overgaard J. Squamous cell carcinoma of the oropharynx-an analysis of treatment results in 289 consecutive patients. Acta Oncol 39 (2000) 985-994
20. Sundaram K., Schwartz J., Har-El G., et al. Carcinoma of the oropharynx: Factors affecting outcome. Laryngoscope 115 (2005) 1536-1542
21. Grau C., and Overgaard J. Significance of Hb concentration for treatment outcome (1997), Springer Verlag, Heidelberg
22. Overgaard J., Hansen H.S., Jorgensen K., et al. Primary radiotherapy of larynx and pharynx carcinoma-an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 12 (1986) 515-521
23. van Acht M.J., Hermans J., Boks D.E., et al. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother Oncol 23 (1992) 229-235
24. Denis F., Garaud P., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22 (2004) 69-76
25. Marcus B., Arenberg D., Lee J., et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 101 (2004) 2779-2787
26. Selek U., Garden A.S., Morrison W.H., et al. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 59 (2004) 743-751
27. Vaupel P., Mayer A., and Hockel M. Impact of hemoglobin levels on tumor oxygenation: The higher, the better?. Strahlenther Onkol 182 (2006) 63-71
28. Nordsmark M., and Overgaard J. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 43 (2004) 396-403
29. Prosnitz R.G., Yao B., Farrell C.L., et al. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1087-1095
30. Koukourakis M.I., Bentzen S.M., Giatromanolaki A., et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 24 (2006) 727-735
31. Koukourakis M.I., Giatromanolaki A., Liberis V., et al. Hypoxia inducible factor 1 alpha and 2 alpha expression is independent of anemia in patients with stage I endometrial cancer. Anticancer Res 22 (2002) 4137-4140
32. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 59 (2004) 67-71
33. Burri P., Djonov V., Aebersold D.M., et al. Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 494-501
34. Ishikawa H., Sakurai H., Hasegawa M., et al. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. Int J Radiat Oncol Biol Phys 60 (2004) 513-521
35. Semenza G.L. Development of novel therapeutic strategies that target HIF-1. Expert Opin Ther Targets 10 (2006) 267-280